Literature DB >> 19076696

Review: Mitochondria and disease progression in multiple sclerosis.

D Mahad1, H Lassmann, D Turnbull.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Recent evidence suggests that dysfunction of surviving demyelinated axons and axonal degeneration contribute to the progression of MS. We review the evidence for and potential mechanisms of degeneration as well as dysfunction of chronically demyelinated axons in MS with particular reference to mitochondria, the main source of adenosine-5'-triphosphate in axons. Besides adenosine-5'-triphosphate production, mitochondria play an important role in calcium handling and produce reactive oxygen species. The mitochondrial changes in axons lacking healthy myelin sheaths as well as redistribution of sodium channels suggest that demyelinated axons would be more vulnerable to energy deficit than myelinated axons. A dysfunction of mitochondria in lesions as well as in the normal-appearing white and grey matter is increasingly recognized in MS and could be an important determinant of axonal dysfunction and degeneration. Mitochondria are a potential therapeutic target in MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19076696      PMCID: PMC2981078          DOI: 10.1111/j.1365-2990.2008.00987.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  123 in total

1.  Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes.

Authors:  I Medana; M A Martinic; H Wekerle; H Neumann
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 2.  Mitochondrial respiratory-chain diseases.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

3.  Axon loss in multiple sclerosis.

Authors:  N Scolding; R Franklin
Journal:  Lancet       Date:  1998-08-01       Impact factor: 79.321

4.  Conduction in segmentally demyelinated mammalian central axons.

Authors:  P A Felts; T A Baker; K J Smith
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

5.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases.

Authors:  M W Cleeter; J M Cooper; V M Darley-Usmar; S Moncada; A H Schapira
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

6.  The influence of sulfide and cyanide on axonal function.

Authors:  J F Beck; J C Donini; A Maneckjee
Journal:  Toxicology       Date:  1983-01       Impact factor: 4.221

7.  Oxidative damage to DNA in plaques of MS brains.

Authors:  O Vladimirova; J O'Connor; A Cahill; H Alder; C Butunoi; B Kalman
Journal:  Mult Scler       Date:  1998-10       Impact factor: 6.312

8.  Histopathology and serial, multimodal magnetic resonance imaging in a multiple sclerosis variant.

Authors:  S Lindquist; N Bodammer; J Kaufmann; F König; H-J Heinze; W Brück; M Sailer
Journal:  Mult Scler       Date:  2007-02-09       Impact factor: 6.312

9.  Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline.

Authors:  K J Smith; H Bostock; S M Hall
Journal:  J Neurol Sci       Date:  1982-04       Impact factor: 3.181

Review 10.  Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy.

Authors:  Kenneth J Smith
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

View more
  65 in total

Review 1.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

Review 2.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

3.  High dose thiamine improves fatigue in multiple sclerosis.

Authors:  Antonio Costantini; Agostino Nappo; Maria Immacolata Pala; Antonietta Zappone
Journal:  BMJ Case Rep       Date:  2013-07-16

Review 4.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

Review 5.  Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.

Authors:  Tobias Derfuss; Chris Linington; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Mol Med (Berl)       Date:  2010-05-06       Impact factor: 4.599

6.  Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.

Authors:  Sungpil Han; Yen Chih Lin; Tianxia Wu; Alan D Salgado; Ina Mexhitaj; Simone C Wuest; Elena Romm; Joan Ohayon; Raphaela Goldbach-Mansky; Adeline Vanderver; Adriana Marques; Camilo Toro; Peter Williamson; Irene Cortese; Bibiana Bielekova
Journal:  J Immunol       Date:  2014-02-07       Impact factor: 5.422

Review 7.  Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions.

Authors:  Linnea R Freeman; Jeffrey N Keller
Journal:  Biochim Biophys Acta       Date:  2011-12-20

8.  Impaired mitochondrial functions in organophosphate induced delayed neuropathy in rats.

Authors:  Anwar Masoud; Ravi Kiran; Rajat Sandhir
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

Review 9.  Oligodendrocytes: biology and pathology.

Authors:  Monika Bradl; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2009-10-22       Impact factor: 17.088

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.